|
C12ORF29 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.32029999658323E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.75229949942002E-10 |
| Normal-vs-Stage2 |
7.887800E-02 |
| Normal-vs-Stage3 |
6.034600E-01 |
| Normal-vs-Stage4 |
6.379600E-02 |
| Stage1-vs-Stage2 |
3.481600E-01 |
| Stage1-vs-Stage3 |
3.836600E-04 |
| Stage1-vs-Stage4 |
1.45210000024321E-07 |
| Stage2-vs-Stage3 |
2.176000E-01 |
| Stage2-vs-Stage4 |
9.224000E-03 |
| Stage3-vs-Stage4 |
3.458100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.89910004073135E-09 |
| Normal-vs-AfricanAmerican |
2.482000E-03 |
| Normal-vs-Asian |
6.102000E-01 |
| Caucasian-vs-AfricanAmerican |
2.447400E-01 |
| Caucasian-vs-Asian |
3.037400E-01 |
| AfricanAmerican-vs-Asian |
6.052400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.39069999960384E-09 |
| Normal-vs-Female |
9.738400E-03 |
| Male-vs-Female |
1.329870E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.998800E-04 |
| Normal-vs-Extreme_Weight |
4.85520001980433E-09 |
| Normal-vs-Obese |
1.616900E-04 |
| Normal-vs-Extreme_Obese |
1.030490E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.357400E-01 |
| Normal_Weight-vs-Obese |
9.988800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.568600E-01 |
| Extreme_Weight-vs-Obese |
2.051200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.309200E-01 |
| Obese-vs-Extreme_Obese |
3.720200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.213400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.78759999999567E-05 |
| Normal-vs-Age(61-80Yrs) |
2.15150008919807E-10 |
| Normal-vs-Age(81-100Yrs) |
2.939000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.419900E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.158610E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.859100E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.549940E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.314790E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.043800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.37810001982808E-09 |
| Normal-VS-Type2 PRCC |
5.320200000547E-07 |
| Normal-VS-KIRP CIMP |
1.926140E-02 |
| Normal-VS-Unclassified PRCC |
8.037100E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.610200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.02369999541463E-08 |
| Type1 PRCC-VS-Unclassified PRCC |
6.398000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.19720000000012E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
3.707800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.570400E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.447600E-04 |
| Normal-vs-N1 |
1.231570E-01 |
| Normal-vs-N2 |
2.898400E-01 |
| N0-vs-N1 |
3.025400E-04 |
| N0-vs-N2 |
8.979600E-01 |
| N1-vs-N2 |
1.082450E-01 |
|
|
